meningitis

(redirected from Menactra)
Also found in: Thesaurus, Medical, Encyclopedia.

men·in·gi·tis

 (mĕn′ĭn-jī′tĭs)
n.
Inflammation of the meninges of the brain and the spinal cord, most often caused by a bacterial or viral infection and characterized by fever, vomiting, intense headache, and stiff neck.

men′in·git′ic (-jĭt′ĭk) adj.

meningitis

(ˌmɛnɪnˈdʒaɪtɪs)
n
(Pathology) inflammation of the membranes that surround the brain or spinal cord, caused by infection
meningitic adj

men•in•gi•tis

(ˌmɛn ɪnˈdʒaɪ tɪs)

n.
inflammation of the meninges, esp. of the pia mater and arachnoid, caused by a bacterial or viral infection and characterized by high fever, severe headache, and stiff neck or back muscles.
[1820–30]
men`in•git′ic (-ˈdʒɪt ɪk) adj.

men·in·gi·tis

(mĕn′ĭn-jī′tĭs)
Inflammation of the membranes (meninges) that enclose the brain and spinal cord, usually resulting from a bacterial infection.

meningitis

Inflammation of the linings of the brain (meninges) usually caused by a virus.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.meningitis - infectious disease characterized by inflammation of the meninges (the tissues that surround the brain or spinal cord) usually caused by a bacterial infectionmeningitis - infectious disease characterized by inflammation of the meninges (the tissues that surround the brain or spinal cord) usually caused by a bacterial infection; symptoms include headache and stiff neck and fever and nausea
choriomeningitis - a cerebral meningitis with cellular infiltration of the meninges
infectious disease - a disease transmitted only by a specific kind of contact
brain fever, cerebrospinal fever, cerebrospinal meningitis, epidemic meningitis - meningitis caused by bacteria and often fatal
cerebromeningitis, encephalomeningitis, meningoencephalitis - inflammation of the brain and spinal cord and their meninges
leptomeningitis - inflammation of the leptomeninges
Translations
إلْتِهاب السَّحاياالْتِهَابُ الْسَّحَايَا
meningitidazánět mozkových blan
meningitis
aivokalvontulehdus
meningitis
agyhártyagyulladás
heilahimnubólga
髄膜炎
뇌수막염수막염
meningitas
meningīts
zápal mozgových blán
hjärnhinneinflammation
เยื่อหุ้มสมองอักเสบ
viêm màng não

meningitis

[ˌmenɪnˈdʒaɪtɪs] Nmeningitis f inv

meningitis

[ˌmɛnɪndˈʒaɪtɪs] nméningite f

meningitis

meningitis

[ˌmɛnɪnˈdʒaɪtɪs] nmeningite f

meningitis

(meninˈdʒaitis) noun
a serious disease in which there is inflammation of the membranes round the brain or spinal cord.

meningitis

الْتِهَابُ الْسَّحَايَا meningitida meningitis Hirnhautentzündung μηνιγγίτιδα meningitis aivokalvontulehdus méningite meningitis meningite 髄膜炎 수막염 meningitis hjernehinnebetennelse zapalenie opon mózgowych meningite менингит hjärnhinneinflammation เยื่อหุ้มสมองอักเสบ menenjit viêm màng não 脑膜炎

men·in·gi·tis

n. meningitis, infl. de las meninges cerebrales o espinales;
cryptococcal ______ criptocócica;
meningcoccal ______ meningocócica;
viral ______ viral.

meningitis

n meningitis f
References in periodicals archive ?
A second vaccine for meningococcal disease (Menactra) is being studied in the Menactra Vaccine Pregnancy Registry (800-822-2463 / www.
Food and Drug Administration (FDA) has approved the use of Sanofi Pasteur's bacterial meningitis vaccine Menactra in children as young as 9 months.
The Ontario government will supply the vaccine, Menactra, for use in the voluntary school-based immunization program for Grade seven students.
But representatives from Menactra manufacturer Sanofi Pasteur assured the committee that the company's total vaccine supply from January 2007 to September 2007 is on track to exceed 6 million doses resulting from surplus carried over from 2006 when the vaccine was deferred in the younger adolescents.
Menactra, developed by Sanofi Pasteur, is expected to offer longer protection than earlier meningitis vaccines.
Aventis (Swiftwater, PA), part of the Sanofi-Aventis Group, announced that the Vaccines and Related Biological Products Advisory Committee of the United States Food and Drug Administration (FDA) voted unanimously to recommend licensure of Menactra (Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate) Vaccine for protection against invasive meningococcal disease in adolescents and adults aged 11-55 years.
Take Care Clinic nurse practitioners and physician assistants can administer appropriate immunizations for school-aged children, such as flu, Tdap (tetanus, diphtheria, pertussis), Menactra (meningitis), Varicella (chicken pox), MMR (measles, mumps, rubella) and GARDASIL[R] (HPV).
Tetravalan konjuge meningokok asisi (MCV-4, Menactra, Sanofi Pasteur), ABD'de 2005 yilinda 11-55 yas icin ruhsat almis ve 11-12 yas grubu cocuklar icin rutin asilama baslatilmistir (39).
In 2007, ACIP recommended that the quadrivalent meningococcal conjugate vaccine (MCV4), sold under the brand names Menactra and Menveo, be given to 11-to 12-year-olds at the established preteen visit, and to 13- to 18-year-olds who had not been previously vaccinated.
10 Studies with Menactra [Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine] and Adacel [Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (Tdap)]
In 2005, a newer quadrivalent conjugated vaccine with protection against ACWY serogroups, Menactra (MCV4) was recommended for use in US adolescents.
The FDA licensed Menactra vaccine on January 14 this year for use among 11 through 55 year olds.